Table 1.
Study characteristics and intervention.
Table 2.
Patient characteristics.
Table 3.
Swab results.
Figure 1.
PFGE subtypes.
Table 4.
Hazard ratios for covariates associated with MRSA acquisition.
Figure 2.
Segmented regression model. Incidence of MRSA per 1000 at risk patient days in ICU over the study period.
There was a decline in MRSA acquisition of 7% per month in the intervention phase, which was a significant change in slope compared with the control phase (95% CI for change in slope 1.9 to 12.8% reduction). The dark blue lines are the data, the black lines are the model best fit results and the light blue lines are the upper and lower values of the 95% credible intervals for the model estimates.